HangZhou Fanttest Biotech Co,. Ltd.
HangZhou Fanttest Biotech Co,. Ltd.

Single and Multi-Drug Rapid Test

Single and Multi-Drug Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of multiple drugs and drug metabolites in urine.

Contact Us
15 In 1 Operation Specification

Single and Multi-Drug Rapid Test 15 In 1

single-and-multi-drug-rapid-test-15-in-1.png

View More View Less

Single and Multi-Drug Rapid Test Operation Steps And Result Interpretation

single-and-multi-drug-rapid-test-.png


Positive (+): Only a purple-red band appears in the quality control area (C). There is no purple-red band in the detection area (T).

Negative (-):Two purple-red bands appear. One is located in the detection area (T), and the other is located in the quality control area (C).

Invalid: There is no purple-red band in the quality control area (C).indicating incorrect handling or deterioration of the reagent.


View More View Less

Single and Multi-Drug Rapid Test Specification

Product nameSingle and Multi-Drug Rapid Test
SpecificationUrineUrine
FormatPanelCup
Pack/Box25T25T
Expiration date24 months
Storage temperature2-30℃
Certifificatece-certificate.png


View More View Less
Please Contact Us
Please Contact Us

To monitor your health status anytime, anywhere and achieve self-inspection and self-testing.

07/03
2025
Fanttest Biotech will attend the Exhibition at World Health Expo Lab 2025 in Kuala Lumpur, Malaysia
Fanttest Biotech is pleased to announce our participation in the World Health Expo Lab (WHX 2025), one of the most prominent international exhibitions in the field of healthcare diagnostics and biotec...
06/16
2025
Fanttest Biotech's H. pylori Product Approved by Hong Kong Department of Health!
On April 30, 2025, Hangzhou Fanttest Biotech (hereinafter referred to as “Fanttest”) announced that its independently developed Helicobacter pylori (H. pylori) diagnostic product has successfully pa...
06/13
2025
COVID Is Still Around and a Risk to Susceptible People. What Are the Symptoms in 2025?
Most people who contract COVID today will only experience mild symptoms. However, some individuals remain at risk of severe illness and are more likely to be hospitalised. This includes older adults, ...